Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model

60

Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model

Tags:

Previous Article

How muscle cells grow and stay healthy

MicroRNA-based gene therapy to treat ALS

Related Posts

Reversal of diet-induced obesity by central insulin sensitizer FSTL1

Reversal of diet-induced obesity by central insulin sen...

88

Energy constraint on human health

Energy constraint on human health

66

Advancing precision medicine in metabolic dysfunction-associated steatotic liver disease

Advancing precision medicine in metabolic dysfunction-a...

94